Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.26.3 (
RNase III
)
1,015
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
cis
-Antisense RNAs (asRNAs) provide very simple and effective gene expression control due to the perfect complementarity between regulated and regulatory transcripts. In
Streptomyces
, the antibiotic-producing clade, the antisense control system is not yet understood, although it might direct the organism's complex development. Initial studies in
Streptomyces
have found a number of asRNAs. Apart from this, hundreds of mRNAs have been shown to bind
RNase III
, the double strand-specific endoribonuclease. In this study, we tested 17 mRNAs that have been previously co-precipitated with
RNase III
for antisense expression. Our
RACE
mapping showed that all of these mRNAs possess cognate asRNA. Additional tests for antisense expression uncovered
as-adpA, as-rnc, as3983, as-sigB, as-sigH
, and
as-sigR
RNAs. Northern blots detected the expression profiles of 18 novel transcripts. Noteworthy, we also found that only a minority of asRNAs respond to the absence of
RNase III
enzyme by increasing their cellular levels. Our findings suggest that antisense expression is widespread in
Streptomyces
, including genes of such important developmental regulators, as AdpA,
RNase III
, and sigma factors.
...
PMID:RNase III-Binding-mRNAs Revealed Novel Complementary Transcripts in
Streptomyces
. 2937 87